Amylyx Pharmaceuticals, Inc. (AMLX) income statement
AMLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$26.02−0.18 (-0.69%)
Close on Nov 20, 2026Market cap $2.90BP/E –Yield –
Amylyx Pharmaceuticals, Inc. financial ratios
See a number that looks wrong?